| 摘要 |
A novel cytokine composition, the method for its preparation and the use of the composition in the immunotherapy of various diseases such as bacterial infections, viral infections and cancers is disclosed. The novel method involves adding two novel ingredients, which are termed transal and a complex of proteinase inhibitors to a virally-induced leukocyte culture. The resulting cytokine composition comprises human leukocyte interferon, Interleuken 1, Tumor Necrosis Factor, Migration Inhibitory Factor, and Leukocyte Migration Inhibition Factor in their naturally occurring ratio.
|
